Global prostate cancer disparities and the parts both genetic and behavioural factors play
Global prostate cancer disparities and the parts both genetic and behavioural factors play
New players and targets in tumour vasculature
ecancermedicalscience editor's choice for July and August 2014
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion
Melanoma live: Making patient-focused therapy decisions
Quality of life and cost advantages of metronomics and drug repurposing
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies
Industry view of targeted therapy combinations in oncology
Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination
WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care
Work of the WIN consortium and challenges of personalised cancer therapy
Combining immunological and targeted agents in melanoma